| 2016 | Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials
| INFECTION AND CHEMOTHERAPY |
| 2023 | Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
| DIABETES & METABOLISM |
| 2013 | Efficacy and safety of entecavir plus carnitine complex (GODEX?) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2017 | Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2021 | Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis
| EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES |
| 2023 | Efficacy and Safety of Epidermidibacterium Keratini EPI-7 Derived Postbiotics in Skin Aging: A Prospective Clinical Study
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2013 | Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2021 | Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
| TRANSPLANTATION |
| 2018 | Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study | AMERICAN JOURNAL OF TRANSPLANTATION |
| 2022 | Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial | DIABETES OBESITY & METABOLISM |
| 2020 | Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)
| DIABETES OBESITY & METABOLISM |
| 2021 | Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study
| CLINICAL THERAPEUTICS |
| 2023 | Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis
| GUT AND LIVER |
| 2019 | Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial | DIABETES OBESITY & METABOLISM |
| 2016 | Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2020 | Efficacy and Safety of Flow-Diverter Therapy for Recurrent Aneurysms After Stent-Assisted Coiling | AMERICAN JOURNAL OF NEURORADIOLOGY |
| 2023 | Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
| JOURNAL OF CLINICAL NEUROLOGY |
| 2020 | Efficacy and Safety of Gemigliptin as Add-On Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (ZEUS II Study) | DIABETES OBESITY & METABOLISM |
| 2019 | Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus | TRANSPLANTATION PROCEEDINGS |
| 2020 | Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis
| GUT AND LIVER |
